Kyttaro
The startup develops targeted therapeutics for hypertriglyceridemia, atherosclerotic cardiovascular disease, and inflammatory conditions using advanced pharmacological methods. Their treatments aim to reduce disease progression and improve patient outcomes in cardiovascular health.
Traction –/10
London, United Kingdom · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted therapeutics for hypertriglyceridemia, atherosclerotic cardiovascular disease, and inflammatory conditions using advanced pharmacological methods. Their treatments aim to reduce disease progression and improve patient outcomes in cardiovascular health.